more about our value

Vivia Biotech dates its origins back to an American team that developed the first technology worldwide enabling scale research in oncology patient samples: PharmaFlow PM Technology Platform, a precision medicine test that allows the profiling of thousands of drugs and combinations in a single patient sample.

In September 2007 Vivia Biotech moved to Spain as an opportunity to efficiently leverage Spain world-leading position in altruistically donation of tissue and organ samples for research.

Since then, Vivia Biotech works on the development of individualized strategies for the treatment of hematologic malignances, such as Leukemia and Multiple Myeloma, and Solid Tumor, in order to identify the best therapeutic option for each individual patient.